ArticleLa Radiologia medica2026
Predictive value of combined cerebral blood volume index and systemic inflammation indices for 90-day functional outcomes following endovascular treatment in patients with acute ischemic stroke and proximal large vessel occlusion: machine learning model construction and population attributable fraction analysis.
Article in La Radiologia medica, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
backgroundWe investigated whether the cerebral blood volume (CBV) index and pretreatment systemic inflammatory indices (SIIs) provide complementary prognostic information for 90-day functional outcomes after successful endovascular therapy (EVT) for anterior circulation large vessel occlusion and evaluated the advantages of machine learning models in terms of prognostic outcomes and quantified adverse outcomes using the population attributable fraction (PAF).
methodsThis retrospective analysis of a prospective registry included 474 patients who were treated between November 2020 and June 2024. An independent 53-patient multicenter cohort was used for external validation. SIIs were calculated from the first venous sample obtained at presentation, before intravenous thrombolysis, and before arterial puncture for EVT. Multivariate logistic regression and eight predictive algorithms were evaluated. PAF estimates were considered exploratory.
resultsAmong 474 patients, 41.6% and 28.5% achieved favorable and excellent outcomes, respectively. Higher CBV indices were more frequent among patients with favorable outcomes, whereas higher inflammatory indices were associated with worse outcomes. Logistic regression showed the highest AUC for mRS 0-2 (0.868, 95% CI 0.806-0.929), while SVM had the highest AUC for mRS 0-1 (0.839, 95% CI 0.764-0.915). The external validation AUCs were 0.816 and 0.802. PAF analysis indicated that improving the CBV index increased favorable and excellent outcomes by 97.2% and 74.8%, respectively, whereas reducing inflammatory overactivation improved them by 22.4%-39.7% and 51.2%-59.5%, respectively.
conclusionBaseline CBV index and pretreatment SII values provided complementary prognostic information after successful EVT. However, prospective validation in a broader population is required before clinical implementation.
Indexed as
Identifiers
42909771What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.